Cary Street Partners Investment Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-195
| Closed | -$29.8K | – | 568 |
|
|
2024
Q4 | $29.8K | Sell |
195
-1,706
| -90% | -$261K | 0.02% | 371 |
|
|
2024
Q3 | $368K | Buy |
1,901
+57
| +3% | +$11K | 0.01% | 568 |
|
|
2024
Q2 | $427K | Buy |
1,844
+19
| +1% | +$4.41K | 0.02% | 510 |
|
|
2024
Q1 | $394K | Sell |
1,825
-8
| -0.4% | -$1.73K | 0.02% | 507 |
|
|
2023
Q4 | $474K | Sell |
1,833
-122
| -6% | -$31.6K | 0.02% | 435 |
|
|
2023
Q3 | $502K | Buy |
1,955
+45
| +2% | +$11.6K | 0.03% | 400 |
|
|
2023
Q2 | $544K | Hold |
1,910
| – | – | 0.04% | 344 |
|
|
2023
Q1 | $531K | Hold |
1,910
| – | – | 0.04% | 327 |
|
|
2022
Q4 | $529K | Sell |
1,910
-13
| -0.7% | -$3.6K | 0.04% | 325 |
|
|
2022
Q3 | $513K | Buy |
1,923
+207
| +12% | +$55.2K | 0.04% | 308 |
|
|
2022
Q2 | $350K | Buy |
+1,716
| New | +$350K | 0.03% | 336 |
|
|
2021
Q3 | – | Sell |
-120
| Closed | -$42K | – | 256 |
|
|
2021
Q2 | $42K | Buy |
120
+5
| +4% | +$1.75K | 0.01% | 292 |
|
|
2021
Q1 | $32K | Buy |
+115
| New | +$32K | 0.01% | 282 |
|
|
2020
Q4 | – | Sell |
-4,764
| Closed | -$1.35M | – | 405 |
|
|
2020
Q3 | $1.35M | Buy |
+4,764
| New | +$1.35M | 0.29% | 107 |
|